{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:14:45Z","timestamp":1758359685722,"version":"3.44.0"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.2169\/internalmedicine.4951-24","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:12:30Z","timestamp":1740157950000},"page":"2790-2793","source":"Crossref","is-referenced-by-count":1,"title":["Severe Systemic Lupus Erythematosus with Anti-centromere Antibody"],"prefix":"10.2169","volume":"64","author":[{"given":"Wataru","family":"Fujii","sequence":"first","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Seno","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kohno","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikoi","family":"Omatsu","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mihara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kawahito","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 1151-1159, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69: 2074-2082, 2010.","DOI":"10.1136\/ard.2010.130476"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Damoiseaux J, Andrade LEC, Casballo OG, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis 78: 879-889, 2019.","DOI":"10.1136\/annrheumdis-2018-214436"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72: 1747-1755, 2013.","DOI":"10.1136\/annrheumdis-2013-eular.238"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren&apos;s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69: 35-45, 2017.","DOI":"10.1002\/art.39859"},{"key":"6","unstructured":"6. Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 27: 1403-1407, 2000."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gong M, Dai L, Xie Z, et al. Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus. Sci Rep 13: 10101, 2023.","DOI":"10.1038\/s41598-023-37100-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Respaldiza N, Wichmann I, Oca\u00f1a C, et al. Anti-centromere antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 35: 290-294, 2006.","DOI":"10.1080\/03009740600588376"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hashimoto A, Endo H, Kondo H, Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol 22: 272-279, 2012.","DOI":"10.3109\/s10165-011-0515-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4951-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T03:28:08Z","timestamp":1758338888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4951-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":9,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4951-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"4951-24"}}